Colgate-Palmolive Pakistan Announces 320% Interim Cash Dividend for Shareholders

Karachi: Colgate-Palmolive (Pakistan) Limited has announced an interim cash dividend of Rs. 32.00 per share for its shareholders, marking a significant 320% return on each Rs. 10.00 share for the fiscal year ending June 30, 2025. This declaration was made during the meeting of the Board of Directors held on January 24, 2025. The interim dividend will be distributed to shareholders whose names are listed on the Members Register by February 06, 2025.

The company's share transfer books will remain closed from February 07, 2025, to February 09, 2025, to determine the entitlement to the interim cash dividend. Transfers received at the office of the Shares Registrar, M/s. FAMCO Share Registration Services (Pvt.) Limited, by the close of business on February 06 will be considered timely for the above entitlement.

According to information available from the Pakistan Stock Exchange (PSX), shareholders are advised to promptly notify any changes in their addresses to the Shares Registrar if shares are held in physical form or to their participant or CDC Investor Accounts Services if held in scripless form. In compliance with the law, tax will be deducted unless a valid tax exemption certificate or a stay order from a competent court is presented before the book closure.

Shareholders with joint shareholding must notify their proportions to the Shares Registrar within five days of this notice. If no proportions are advised, equal shareholding will be assumed, and withholding tax will be deducted based on the active or non-active taxpayer status of each joint-holder.

Under Section 242 of the Companies Act, 2017, dividends will be paid only through electronic mode directly into the bank accounts designated by entitled shareholders. Shareholders are urged to complete the Electronic Credit Mandate Form available on the company's website and submit it along with a copy of their CNIC to the Shares Registrar for physical shares. Those holding shares in CDC should submit the form to their broker/participant/CDC account services. No further action is required if the IBAN is already updated in the shareholder's CDC account or physical folio.

In a bid to streamline processes, shareholders who have not yet submitted copies of their valid CNICs are requested to do so promptly to ensure smooth processing of their dividend entitlements.